SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Helsinn Grants to DARA BioSciences, Inc. Exclusive U.S. Commercial Rights to Gelclair®, an FDA-Cleared Oral Gel for the Treatment of Oral Mucositis